Psychedelic Therapeutics Take Center Stage: FDA Announces Public Hearing And Finalizes Clinical Guidance
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 19 August 2026
What it is about
Who published it, and when
How it spread - 1 original report
Wed, 19 August 2026
1 report- mondaq.com04:23first to report
The FDA has announced a September 2026 public hearing to gather stakeholder feedback on the therapeutic use of psychedelic drugs in supervised settings, marking a significant federal policy shift following the Trump administration's Executive Order directing agencies to accelerate psychedelic drug research and approval. This development, coupled with newly released FDA guidance on clinical investigations, signals an evolving regulatory landscape that extends beyond traditional drug approval...